Across TCGA pan-cancer cohorts, FNDC3A RNA is linked to patient survival in 30 of 34 cancer types, making it the most broadly survival-associated FNDC3A data layer compared with 9 for mutation status and 6 for mass-spec protein.
The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher FNDC3A RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FNDC3A expression acts as an unfavorable survival marker, although some lineages such as KIRC and UCEC show a favorable association.
CESC, KIRC, and LUSC are the cancer types where FNDC3A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.